We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TXNM
351
TXNM Energy Inc
TXNM
$6.47B
| $4.81M | 0.07% |
94,490
+18,550
| +24% | +$885K |
|
352
Carlisle Companies
CSL
$13.6B
| $4.77M | 0.07% |
33,980
+9,490
| +39% | +$1.28M |
|
353
Medtronic
MDT
$107B
| $4.77M | 0.07% |
48,980
-35,230
| -42% | -$3.22M |
|
354
MYR Group
MYRG
$5.9B
| $4.74M | 0.07% |
126,826
+1,140
| +0.9% | +$39.7K |
|
|
SF
355
Stifel
SF
$12.3B
| $4.74M | 0.07% |
+180,428
| New | +$4.59M |
|
356
TriCo Bancshares
TCBK
$1.85B
| $4.7M | 0.07% |
124,325
+18,230
| +17% | +$712K |
|
|
RST
357
DELISTED
ROSETTA STONE INC
RST
| $4.67M | 0.06% |
203,938
-87,336
| -30% | -$2.1M |
|
|
SRDX
358
DELISTED
Surmodics
SRDX
| $4.65M | 0.06% |
107,790
+700
| +0.7% | +$29.5K |
|
359
Accuray
ARAY
$28.4M
| $4.64M | 0.06% |
1,199,211
+9,400
| +0.8% | +$38K |
|
|
MODN
360
DELISTED
MODEL N, INC.
MODN
| $4.6M | 0.06% |
235,810
+85,621
| +57% | +$1.58M |
|
361
AdvanSix
ASIX
$567M
| $4.56M | 0.06% |
186,710
+38,963
| +26% | +$1.09M |
|
362
First Bancorp
FBNC
$2.6B
| $4.52M | 0.06% |
124,016
+14,870
| +14% | +$544K |
|
363
Dentsply Sirona
XRAY
$2.59B
| $4.52M | 0.06% |
+77,395
| New | +$4.16M |
|
364
CoreCivic
CXW
$3.1B
| $4.5M | 0.06% |
216,994
-84,574
| -28% | -$1.82M |
|
365
Enterprise Financial Services Corp
EFSC
$2.41B
| $4.5M | 0.06% |
108,196
-16,498
| -13% | -$690K |
|
|
ECHO
366
DELISTED
Echo Global Logistics, Inc.
ECHO
| $4.5M | 0.06% |
215,394
-4,061
| -2% | -$90.1K |
|
367
Jack in the Box
JACK
$278M
| $4.49M | 0.06% |
55,100
-5,150
| -9% | -$416K |
|
368
Calix
CALX
$2.27B
| $4.48M | 0.06% |
683,434
+36,348
| +6% | +$245K |
|
|
AMAG
369
DELISTED
AMAG Pharmaceuticals
AMAG
| $4.47M | 0.06% |
447,715
+179,310
| +67% | +$1.93M |
|
370
HealthStream
HSTM
$793M
| $4.47M | 0.06% |
172,700
+5,320
| +3% | +$140K |
|
371
Piper Sandler
PIPR
$5.14B
| $4.46M | 0.06% |
240,288
+110,224
| +85% | +$2.08M |
|
372
C.H. Robinson
CHRW
$22B
| $4.45M | 0.06% |
52,700
+2,730
| +5% | +$230K |
|
373
Group 1 Automotive
GPI
$3.94B
| $4.44M | 0.06% |
54,231
-18,834
| -26% | -$1.42M |
|
374
Forward Air
FWRD
$482M
| $4.42M | 0.06% |
74,757
-21,620
| -22% | -$1.33M |
|
|
WBA
375
DELISTED
Walgreens Boots Alliance
WBA
| $4.38M | 0.06% |
80,150
+73,560
| +1,116% | +$3.91M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.